financetom
Business
financetom
/
Business
/
Peoples Bancorp's Q1 Earnings Rise, Revenue Declines, Tops Guidance; Raises Quarterly Dividend
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Peoples Bancorp's Q1 Earnings Rise, Revenue Declines, Tops Guidance; Raises Quarterly Dividend
Apr 23, 2024 6:40 AM

09:08 AM EDT, 04/23/2024 (MT Newswires) -- Peoples Bancorp (PEBO) reported Q1 earnings Tuesday of $0.84 per diluted share, down from $0.94 a year earlier.

Analysts surveyed by Capital IQ expected $0.80.

Revenue for the quarter ended March 31, expressed as the sum of net interest income and noninterest income, was $112.4 million, compared with $91.9 million a year earlier.

Analysts surveyed by Capital IQ expected $110.2 million.

The bank also raised its quarterly dividend to $0.40 from $0.39, payable May 20 to shareholders of record as of May 6.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UBS to Pay $986 Million to Resolve Legacy French Tax Case
UBS to Pay $986 Million to Resolve Legacy French Tax Case
Sep 23, 2025
05:41 AM EDT, 09/23/2025 (MT Newswires) -- UBS Group ( UBS ) said Tuesday it has agreed to pay 835 million euros ($985.8 million) to resolve the legacy tax matter pertaining to its cross-border business activities in France between 2004 and 2012. The Swiss banking giant will pay a fine of 730 million euros and 105 million euros in civil...
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company , and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combi
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company , and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combi
Sep 23, 2025
Semnur’s shares of common stock and warrants are expected to trade on the OTC Markets on September 23, 2025 under the ticker symbols “SMNR” and “SMNRW”, respectively.Scilex (together with its affiliates) owns approximately 87.5% of Semnur common stock post Business Combination PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR, SMNRW)...
Update: Firefly Aerospace Q2 Loss Widens, Revenue Falls; Shares Down Pre-Bell
Update: Firefly Aerospace Q2 Loss Widens, Revenue Falls; Shares Down Pre-Bell
Sep 23, 2025
05:47 AM EDT, 09/23/2025 (MT Newswires) -- (Updates with the latest stock price movement in the headline and the first paragraph.) Firefly Aerospace ( FLY ) shares were down nearly 13% in recent premarket activity Tuesday after the company's Q2 loss widened year over year and its revenue fell. The company reported a Q2 net loss late Monday of $5.78...
J&J to withdraw acid reflux device from non-US markets, Bloomberg News reports
J&J to withdraw acid reflux device from non-US markets, Bloomberg News reports
Sep 23, 2025
(Reuters) -Johnson & Johnson ( JNJ ) will withdraw a device to treat acid reflux disease from markets outside the U.S., Bloomberg News reported on Tuesday, citing a company letter sent to doctors. The company has decided to withdraw the product, called LINX Reflux Management System, from March for commercial reasons, and not due to safety or efficacy issues, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved